Application 214091
- Type
- ANDA
- Sponsor
- SCIEGEN PHARMS INC
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | CARBIDOPA AND LEVODOPA | CARBIDOPA; LEVODOPA | TABLET, EXTENDED RELEASE;ORAL | 25MG;100MG | No | No |
| 002 | CARBIDOPA AND LEVODOPA | CARBIDOPA; LEVODOPA | TABLET, EXTENDED RELEASE;ORAL | 50MG;200MG | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 50228-460 | Carbidopa and Levodopa | Carbidopa and Levodopa | ScieGen Pharmaceuticals Inc | ANDA | Current |
| 50228-461 | Carbidopa and Levodopa | Carbidopa and Levodopa | ScieGen Pharmaceuticals Inc | ANDA | Current |